The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Rigel Pharmaceuticals, Inc(NASDAQ:RIGL) 
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocy...
Website: http://www.rigel.com
Founded: 1996
Full Time Employees: 163
Sector: Healthcare
Industry: Biotechnology
Rigel Pharmaceuticals Days Payable Outstanding ttm (DPO)
Rigel Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Rigel Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Rigel Pharmaceuticals Op Cashflow Per Share ttm
Rigel Pharmaceuticals Free Cashflow Per Share ttm
Rigel Pharmaceuticals Cash Per Share ttm
Rigel Pharmaceuticals P/S ratio ttm
Rigel Pharmaceuticals (GAAP) P/E ratio ttm
Rigel Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.